Skip to main content
FinSpry Logo
FinSpry
NTLA logo
NTLA
(NASDAQ)
Intellia Therapeutics, Inc.
$12.74-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Intellia Therapeutics (NTLA) Stock Price & Financial Analysis

Intellia Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.52 - $12.96
52-Week High$28.25
52-Week Low$7.95
Open$12.59
Volume2.79M
Average Volume (3M)3.35M
Market Cap1.51B
Shares Outstanding118.49M
Price to Sales (P/S)22.84
Price to Book (P/B)2.43
EV/EBITDA-3.69
Revenue (TTM)66.09M
Net Income (TTM)-394.60M
Free Cash Flow (TTM)-363.63M
EPS (TTM)$-3.58
Profit Margin-597.04%
Operating Margin-636.56%
Return on Equity (ROE)-63.55%
Debt to Equity0.13
50-Day MA$12.92
200-Day MA$12.55
52-Week Change5.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Intellia Therapeutics

What is the current stock price for NTLA?

As of the latest trading session, NTLA stock trades at $12.74. The 52-week range is $7.95–$28.25, with a day range of $12.52–$12.96.

What is the P/E ratio for NTLA?

The P/E ratio (Price-to-Earnings) for NTLA is shown in the Key Statistics section. This valuation metric helps compare Intellia Therapeutics, Inc. to industry peers.

Does NTLA pay dividends?

Intellia Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NTLA?

Based on 7 analysts, the consensus for NTLA is Buy.

What is the market cap of NTLA?

Intellia Therapeutics's market capitalization is $1.51B, classifying it as a small-cap company. Intellia Therapeutics operates in the Healthcare sector within the Biotechnology industry.